Fatal interaction between ritonavir and MDMA

被引:86
作者
Henry, JA
Hill, IR
机构
[1] St Marys Hosp, Imperial Coll Sch Med, Acad Dept Accid & Emergency Med, London W2 1NY, England
[2] United Med & Dent Sch Guys & St Thomas Hosp, Dept Forens Med, London SE1 9RT, England
关键词
D O I
10.1016/S0140-6736(05)79824-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1751 / 1752
页数:2
相关论文
共 5 条
[1]   Protease inhibitors in patients with HIV disease - Clinically important pharmacokinetic considerations [J].
Barry, M ;
Gibbons, S ;
Back, D ;
Mulcahy, F .
CLINICAL PHARMACOKINETICS, 1997, 32 (03) :194-209
[2]   CLINICAL-SIGNIFICANCE OF THE SPARTEINE-DEBRISOQUINE OXIDATION POLYMORPHISM [J].
BROSEN, K ;
GRAM, LF .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 36 (06) :537-547
[3]   TOXICITY AND DEATHS FROM 3,4-METHYLENEDIOXYMETHAMPHETAMINE (ECSTASY) [J].
HENRY, JA ;
JEFFREYS, KJ ;
DAWLING, S .
LANCET, 1992, 340 (8816) :384-387
[4]  
ROBERTS L, 1993, J ACCID EMERG MED, V11, P53
[5]   THE DEMETHYLENATION OF METHYLENEDIOXYMETHAMPHETAMINE (ECSTASY) BY DEBRISOQUINE HYDROXYLASE (CYP2D6) [J].
TUCKER, GT ;
LENNARD, MS ;
ELLIS, SW ;
WOODS, HF ;
CHO, AK ;
LIN, LY ;
HIRATSUKA, A ;
SCHMITZ, DA ;
CHU, TYY .
BIOCHEMICAL PHARMACOLOGY, 1994, 47 (07) :1151-1156